135830-04-5

1-methyl-1H-imidazo[1,2-b]pyrazole-7-carbonitrile(SALTDATA: FREE)

1-methyl-1H-imidazo[1,2-b]pyrazole-7-carbonitrile(SALTDATA: FREE)

Catalog No.2369789
Name 1-methyl-1H-imidazo[1,2-b]pyrazole-7-carbonitrile(SALTDATA: FREE)
CAS135830-04-5
FormulaC7H6N4

Request a Quote

Structure of 135830-04-5

About 1-methyl-1H-imidazo[1,2-b]pyrazole-7-carbonitrile(SALTDATA: FREE)

1-methyl-1H-imidazo[1,2-b]pyrazole-7-carbonitrile(SALTDATA: FREE) is a chemical compound registered under CAS number 135830-04-5, with the molecular formula C7H6N4 and a molecular weight of about 146.14 g/mol. KingPharm Group supplies 1-methyl-1H-imidazo[1,2-b]pyrazole-7-carbonitrile(SALTDATA: FREE) for laboratory research and bulk production; product code 2369789. Send an inquiry for purity, packaging, price and lead time.

CAS Number
135830-04-5
Molecular Formula
C7H6N4
Molecular Weight
146.14 g/mol

Related Products

  1. Phosphonic dichloride, [1-(chloromethyl)-2-ethoxyethenyl]-
    32394-99-3
  2. Cyclohexanamine, 4-(3,4-dimethylphenyl)-N-methyl-, cis-
    178542-27-3
  3. Naphthalene, 1,2,3,4-tetrahydro-1,1-dimethoxy-
    105644-28-8
  4. Benzeneacetic acid, 3,4-dichloro-alpha-[[(1,1-dimethylethoxy)carbonyl]amino]-, (S)
    1241678-17-0
  5. Phosphonic dichloride, (2-methyl-2-propenyl)-
    58142-39-5
  6. Benzamide,3,5-difluoro-N-[3-[3-oxo-2-(3-pyridinylmethyl)pyrido[2,3-b]pyrazin-4(3H)-yl]phenyl]-
    176031-70-2
  7. Benzoic acid,5-[[2-[(1E)-2-(4-bromo-2-fluorophenyl)ethenyl]-4-oxazolyl]methoxy]-2-[4-[2-(hydroxymethyl)-1H-imidazol-1-yl]butyl]-, methyl ester
  8. Phosphonic dichloride, (2-chloro-4,5-dimethylphenyl)-
  9. 3-(bromomethyl)-pyridine
  10. Phosphonic acid, (2,5,7-trimethyl-4-oxepinyl)-, dimethyl ester
  11. 135830-04-5 msds
  12. CAS No 135830-04-5 supplier
  13. CASNo 135830-04-5 distributor
  14. CAS # 135830-04-5 manufacturer
  15. CAS Number 135830-04-5 safety
  16. CAS RN 135830-04-5 wholesale
  17. 2026-11-06 Find 1-methyl-1H-imidazo[1,2-b]pyrazole-7-carbonitrile(SALTDATA: FREE),CAS No.135830-04-5,Formula:C7H6N4 in KingPharm Group